Benzinga··Usa News GroupBiotech Race to Commercialize Longevity Science Heats Up as Market Eyes $29.7B Prize
Longevity biotech sector surges toward $29.7B market by 2034 as companies advance cell therapies for age-related diseases, with multiple clinical programs showing promising results.
VRTXLGVNLCTXOCGNclinical trialsgene therapy